Professor of Ophthalmology, Johns Hopkins University School of Medicine; Chief - Retina Division
Ophthalmology
Dr. Neil M. Bressler, MD
|
|
Give Review
Doctor Neil M. Bressler, MD is an expert in the field of Ophthalmology. He graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received awards:"America's Top Doctors", "Top Doctors:Baltimore Area", "Top Doctors:Washington-Baltimore", "Super Doctor" and "Fellow (FAAO)". Neil M. Bressler is a published physician as well. He has 95 publications published. The latest was: Comparison of Prevalence of Diabetic Macular Edema Based on Monocular Fundus Photography vs Optical Coherence Tomography. He is registered with Medicare and accepts Medicare payments.
Publications
- Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
- Comparison of Prevalence of Diabetic Macular Edema Based on Monocular Fundus Photography vs Optical Coherence Tomography.
- Three-year patient-reported visual function outcomes in Diabetic macular edema managed with ranibizumab: the RESTORE extension study.
- Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema: Report From RESTORE, RIDE, and RISE Tri...
- Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
- Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive...
- Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States.
- TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL Diabetic MACULAR EDEMA.
- Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema: Results from RIDE and RISE.
- Prevalence of and risk factors for Diabetic macular edema in the United States.
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results.
- Vision-Threatening Lesions Developing with Longer-Term Follow-up after Treatment of Neovascular Age-Related Macular Degeneration.
- Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in Diabetic macular edema.
- Spontaneous improvement in myopic foveoschisis.
- RANIBIZUMAB FOR MACULAR TELANGIECTASIA TYPE 2 IN THE ABSENCE OF SUBRETINAL NeovascularIZATION.
- EARLY DETECTION OF Choroidal NEOVASCULARIZATION FACILITATED WITH A HOME MONITORING PROGRAM IN AGE-RELATED MACULAR DEGENERATION.
- Revolution to a new standard treatment of Diabetic macular edema.
- Pilot study of individuals with diabetic macular edema undergoing Cataract surgery.
- Development of a Preference-Based Index From the National Eye Institute Visual Function Questionnaire-25.
- Underuse of the Health Care System by Persons With Diabetes Mellitus and Diabetic Macular Edema in the United States.
- Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of Diabetic retinopathy in a randomized clinical trial.
- JAMA Ophthalmology: It's Not Just a New Name.
- Reading speed improvements in Retinal vein occlusion after ranibizumab treatment.
- Macular edema after Cataract surgery in eyes without preoperative central-involved diabetic macular edema.
- Green or yellow laser treatment for Diabetic macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research Network.
- A conceptual framework of functional reading independence in geographic atrophy.
- Driving ability reported by Neovascular age-related macular degeneration patients after treatment with ranibizumab.
- Automated Classification of Severity of Age-related Macular Degeneration from Fundus Photographs.
- Author Response: Validation of the National Eye Institute Visual Function Questionnaire-25 (NEIVFQ-25) in Age-Related Macular Degeneration.
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: Three-Year Randomized Trial Results.
- Panretinal photocoagulation for proliferative Diabetic retinopathy.
- Understanding and reporting Visual acuity measurements in publications of clinical research.
- Rasch analysis in the development of a simplified version of the national eye institute Visual-function questionnaire-25 for utility estimation.
- Does Laser Still Have a Role in the Management of Retinal Vascular and Neovascular Diseases?
- Estimated cases of legal blindness and visual impairment avoided using ranibizumab for Choroidal neovascularization: non-Hispanic white population in the United States...
- Patient-reported outcomes among sham vs no-treatment controls from randomized trials.
- Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-related Macular Degeneration.
- Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium.
- Factors associated with visual acuity outcomes after vitrectomy for Diabetic macular edema: Diabetic retinopathy clinical research network.
- Prospective one-year study of ranibizumab for predominantly hemorrhagic Choroidal neovascular lesions in age-related macular degeneration.
- Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from Choroidal neovascularization.
- Management of Macular edema from retinal vein occlusions: you can never have too many choices.
- Comparing Retinal thickness measurements from Cirrus spectral domain- and Stratus time domain-optical coherence tomography.
- A cost-effectiveness analysis of three treatments for age-related Macular degeneration.
- Progression of age-related macular degeneration after Cataract surgery.
- Antiangiogenic approaches to age-related Macular degeneration today.
- Responsiveness of NEI VFQ-25 to changes in visual acuity in Neovascular AMD: validation studies from two phase 3 clinical trials.
- Visual acuity outcomes among sham vs no-treatment controls from randomized trials.
- Optical coherence tomography and Cataract surgery.
- Surgical removal vs observation for idiopathic or ocular histoplasmosis syndrome-associated subfoveal Choroidal neovascularization: Vision Preference Value Scale findi...
- Diabetic macular edema: what is focal and what is diffuse?
- Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related Macular degeneration.
- Vitamin usage patterns in the prevention of advanced age-related Macular degeneration.
- A method of reporting macular edema after Cataract surgery using optical coherence tomography.
- Visual acuity as an outcome measure in clinical trials of Retinal diseases.
- Patients' preferences in choosing therapy for Retinal vein occlusions.
- Analysis of macular edema after Cataract surgery in patients with diabetes using optical coherence tomography.
- The long-term natural history of geographic atrophy from age-related Macular degeneration: enlargement of atrophy and implications for interventional clinical trials.
- Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history study.
- Verteporfin therapy for CNV secondary to OHS.
- Occult with no classic subfoveal Choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions w...
- Hemoglobin A1c awareness among patients receiving eye care at a tertiary ophthalmic center.
- Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the subMacular surgery trials: SST Report No. 16.
- Retinal anastomosis to Choroidal neovascularization: a bum rap for a difficult disease.
- Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioRetinopathy.
- Verteporfin therapy for subfoveal Choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinic...
- Histopathologic and ultrastructural features of surgically excised subfoveal Choroidal neovascular lesions: submacular surgery trials report no. 7.
- Clinicopathologic correlation of occult Choroidal neovascularization in age-related macular degeneration. 1992.
- Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related Macular degeneration. 1994.
- Cystoid Macular edema from niacin typically is not accompanied by fluorescein leakage on angiography.
- Photodynamic therapy with verteporfin: observations on the introduction of a new treatment into clinical practice.
- Choroidal neovascularization after central retinal vein occlusion in a 47-year-old man.
- Retrospective case series of juxtafoveal Choroidal neovascularization treated with photodynamic therapy with verteporfin.
- Advantages and potential dangers of presentation before publication: third in a series on editorship.
- Is adjustment of National Eye Institute Visual Function Questionnaire scores for general health necessary in randomized trials?
- Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with Neovascular age-related macular degeneration.
- Age-related Macular degeneration is the leading cause of blindness...
- Radiation Retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma.
- Detection of Diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography.
- Natural history of minimally classic subfoveal Choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) inves...
- Large subMacular hemorrhages after verteporfin therapy.
- Use of best and final Visual acuity outcomes in ophthalmological research.
- Photodynamic therapy with verteporfin for subfoveal Choroidal neovascularization in children.
- Verteporfin therapy of subfoveal Choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
- Retinal arteriolar narrowing and risk of coronary heart disease.
- A comparison of quantitative mapping and stereoscopic fundus photography grading of retinal thickness in Diabetic eyes with macular edema.
- Retinal pigment epithelium tumorlike lesion arising from an area treated with laser photocoagulation.
- Foveal congenital hypertrophy of the retinal pigment epithelium in the setting of geographic atrophy from age-related Macular degeneration.
- Iatrogenic Choroidal neovascularization occurring in patients undergoing macular surgery.
- Apparent disappearance of Choroidal neovascularization after initial photodynamic therapy with verteporfin.
- Early detection and treatment of Neovascular age-related macular degeneration.
- Verteporfin therapy of subfoveal Choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions wi...
- Intraretinal fibrosis in exudative Diabetic macular edema after ranibizumab treatments.
- Comparison of time- and spectral-domain optical coherence tomography in management of Diabetic macular edema.
Schools
Johns Hopkins University School Of Medicine
Harvard Mass Ee
Johns Hopkins Hospital
WilmerJohns Hopkins Hospital
Conditions Treated
- Benign Neoplasm of Eye
- Cataract
- Choroidal Neovascular Membranes (CNVM)
- Degenerative Disorders of Globe
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
- Super Doctor
- Fellow (FAAO)
Education
-
Johns Hopkins University -
Massachusetts Eye & Ear Infirmary -
Johns Hopkins University School of Medicine
Hospital
-
Howard County General Hospital -
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1790742245 | |
| NPPES Provider LastName | BRESSLER | |
| NPPES Provider FirstName | NEIL | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790742245 |
| Last Name Of The Provider | BRESSLER |
| First Name Of The Provider | NEIL |
| View All |
Similar Doctors
|
|
Dr. Allan D. Jensen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven L. Bernstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander V. On, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eiyass Albeiruti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley Brull, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Corey W. Waldman, MD |
|
|
Dr. Harry Randall II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farhan I. Merali, MD |
|
|
Dr. Justin Marsh, MD |
|
|
Dr. Ala Moshiri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin M. Shaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard B. Jenkins, MD |